Global Predictive Genetic Testing Market 2026–2031: Trends, Growth, and Future Outlook

Introduction

The Predictive Genetic Testing Market is rapidly evolving as healthcare shifts toward preventive and personalized medicine. Predictive genetic testing enables healthcare providers and individuals to assess the risk of developing genetic diseases long before symptoms appear, offering a proactive approach to disease management.

Market Size

According To The Insight Partners, The global Predictive Genetic Testing Market is projected to grow significantly between 2025 and 2031. Valued at approximately US$1.42 billion in 2024, the market is expected to reach around US$4.20 billion by 2031, registering a CAGR of about 17.1% over the forecast period.

Key Market Drivers

Several factors are fueling the expansion of this market:

• Rising Genetic Disease Prevalence: Increasing cases of inherited conditions such as cancer, cardiovascular diseases, and metabolic disorders are driving demand for predictive testing.
• Acceptance of Personalized Medicine: Predictive tests are integral to precision healthcare, helping doctors tailor treatments based on an individual’s genetic profile.
• Growth of Direct‑to‑Consumer (DTC) Testing: Consumers are increasingly choosing at‑home genetic risk assessments for insights into their health and family history.

Get a PDF Copy: https://www.theinsightpartners.com/sample/TIPRE00041693

Market Scope

The market scope defines the boundaries of analysis, helping stakeholders understand:

• Which geographies and segments have the highest growth potential.
• The technologies and testing types driving market expansion.
• Strategic opportunities for new entrants and existing companies in the predictive genetic testing space

Market Segmentation

By Type:

• Predispositional Testing – Identifies future risk based on genetic predisposition.
• Presymptomatic Testing – Detects genetic markers before symptoms develop.

By Disease:

• Cancer
• Cardiovascular Diseases
• Metabolic Diseases
• Other Diseases

By End User:

• Hospital‑Based Laboratories
• Diagnostic Laboratories
• Other End Users

By Region:

• North America
• Europe initiatives
• Asia Pacific
• South & Central America and Middle East & Africa

Market Opportunities

Significant growth opportunities lie in:

• Emerging markets in developing regions, where increased awareness and healthcare expansion can drive adoption of predictive tests
• Expansion of at‑home testing options, giving consumers easier and more affordable ways to understand genetic risk
• Investment in rare disease screening, providing early detection and management pathways.

For More Info: https://www.theinsightpartners.com/reports/predictive-genetic-testing-market

Top Key Leaders

The predictive genetic testing market is highly competitive, featuring global leaders such as:

• Illumina, Inc.
• 23andMe Holding Co.
• F. Hoffmann‑La Roche Ltd.
• Ambry Genetics Corp.
• Myriad Genetics Inc.
• Exact Sciences Corp.

Conclusion

As demand for early disease detection and tailored healthcare solutions continues to rise, predictive genetic testing is set to play a pivotal role in shaping the future of modern medicine, offering both healthcare providers and patients more informed and proactive approaches to disease management.

Related Reports:

Medical Enzyme Technology Market Growth and Outlook (2026-2034)

Home Medical Devices Market Overview and Growth Prospects (2026-2034)